Human Mutation · 2013 · 50 citations · 17 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeurodegenerationGenetic DisordersGenetic SyndromesMolecular Basis Of NeurodegenerationNeurodegenerative Disease GeneticsNeurodegenerative DisordersNeurogenetic DisordersAutosomal Recessive Neurodegenerative DisordersMutation SpectrumMutation Spectrum AnalysisSerine HydrolasesShort Stature AssessmentShort Stature GeneticsSyndromic Hearing Loss
PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the α-β-hydrolase domain-containing 12 gene (ABHD12). Only five homozygous ABHD12 mutations have been reported and the pathogenesis of PHARC remains unclear. We evaluated a woman who manifested short stature as well as the typical features of PHARC. Sequence analysis of ABHD12 revealed a novel heterozygous c.1129A>T (p.Lys377*) mutation. Targeted comparative genomic hybridization detected a 59-kb deletion that encompasses exon 1 of ABHD12 and exons 1-4 of an adjacent gene, GINS1, and includes the promoters of both genes. The heterozygous deletion was also carried by the patient's asymptomatic mother. Quantitative reverse transcription-PCR demonstrated ∼50% decreased expression of ABHD12 RNA in lymphoblastoid cell lines from both individuals. Activity-based protein profiling of serine hydrolases revealed absence of ABHD12 hydrolase activity in the patient and 50% reduction in her mother. This is the first report of compound heterozygosity in PHARC and the first study to describe how a mutation might affect ABHD12 expression and function. The possible involvement of haploinsufficiency for GINS1, a DNA replication complex protein, in the short stature of the patient and her mother requires further studies.
17
A faux 3′-UTR promotes aberrant termination and triggers nonsense- mediated mRNA decay
Nadia Amrani, Robin Ganesan, Stéphanie Kervestin et al. · Nature · 2004 · 526 citations